Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Quant Creates GPCR-Screening Division

NEW YORK, Sept. 5 - Bio-Quant has created a new division designed to offer screening technology for G protein-coupled receptors, the company said on Wednesday.

GPCRs function as the delivery mechanism for more than 50 percent of all drugs currently on the market. To facilitate the discovery of additional GPCRs that might serve as drug targets, Bio-Quant’s new business unit will provide platforms that screen for cell motility and GPCR activation.

“These two platforms for drug discovery will allow biotechnology/pharmaceutical companies to screen their compound libraries much faster and cheaper, enabling them to get to market much sooner,” Bio-Quant CEO Bassam Damaj said in a statement.

As part of the cell motility, or chemotaxis, platform, San Diego-based Bio-Quant’s new division will offer leakage-resistant fluorescent dyes, chemotaxis assays, and imaging devices with liquid-handling capabilities. 

The cell activation platform, also called the intracellular calcium mobilization measurement platform, includes fluorescent CalciDyes and a microplate imaging device.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.